Literature DB >> 15932515

Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome.

T Tanaka1, H Takada, A Nomura, S Ohga, R Shibata, T Hara.   

Abstract

Hyper-immunoglobulin E (IgE) syndrome (HIES) is one of the primary immunodeficiency syndromes. Although the cytokine dysregulation is suggested to play a role in its pathophysiology, the causative gene has not yet been identified. To investigate the pathophysiology and candidate genes involved in this disease, we performed microarray analysis of unstimulated peripheral CD4+ T cells and CD14+ cells, as well as peripheral blood mononuclear cells (PBMNC) stimulated with Staphylococcus aureus isolated from HIES patients and healthy controls. By microarray analysis, 38 genes showed over 2-fold differences between the HIES patients and healthy controls in purified CD14+ cells, although only small differences in the gene expression profiles were observed between the two groups in purified CD4+ T cells. RGC32 expression levels showed the greatest difference between the two groups, and were significantly elevated in HIES compared with those in severe atopic dermatitis or healthy controls using real-time PCR. A significantly larger number of lysosome-related genes were up-regulated, and significantly larger number of genes related to cell growth and maintenance were down-regulated in HIES. After the stimulation of PBMNC with Staphylococcus aureus, 51 genes showed over 3-fold differences between HIES patients and healthy controls. A significantly large number of immunoglobulin-related genes were up-regulated in HIES. The distinct patterns of gene expression profiles and RGC32 expression levels will be useful for understanding the pathophysiology and for diagnosis of HIES, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932515      PMCID: PMC1809394          DOI: 10.1111/j.1365-2249.2005.02805.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo.

Authors:  H Hoshino; M Laan; M Sjöstrand; J Lötvall; B E Skoogh; A Linden
Journal:  J Allergy Clin Immunol       Date:  2000-01       Impact factor: 10.793

2.  Cytokine and chemokine dysregulation in hyper-IgE syndrome.

Authors:  J Chehimi; M Elder; J Greene; L Noroski; E R Stiehm; J A Winkelstein; K E Sullivan
Journal:  Clin Immunol       Date:  2001-07       Impact factor: 3.969

3.  Job's Syndrome. Recurrent, "cold", staphylococcal abscesses.

Authors:  S D Davis; J Schaller; R J Wedgwood
Journal:  Lancet       Date:  1966-05-07       Impact factor: 79.321

4.  Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses.

Authors:  H R Hill; H D Ochs; P G Quie; R A Clark; H F Pabst; S J Klebanoff; R J Wedgwood
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

5.  Extreme hyperimmunoglobulinemia E and undue susceptibility to infection.

Authors:  R H Buckley; B B Wray; E Z Belmaker
Journal:  Pediatrics       Date:  1972-01       Impact factor: 7.124

6.  Genetic linkage of hyper-IgE syndrome to chromosome 4.

Authors:  B Grimbacher; A A Schäffer; S M Holland; J Davis; J I Gallin; H L Malech; T P Atkinson; B H Belohradsky; R H Buckley; F Cossu; T Español; B Z Garty; N Matamoros; L A Myers; R P Nelson; H D Ochs; E D Renner; N Wellinghausen; J M Puck
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

7.  Evolution of the hyperimmunoglobulin E and recurrent infection (HIE, JOB's) syndrome in a young girl.

Authors:  S C Dreskin; J I Gallin
Journal:  J Allergy Clin Immunol       Date:  1987-11       Impact factor: 10.793

8.  Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and beta-N-acetylhexosaminidase release.

Authors:  Gina Lisignoli; Stefania Toneguzzi; Anna Piacentini; Luca Cattini; Anna Lenti; Matilde Tschon; Sandra Cristino; Francesco Grassi; Andrea Facchini
Journal:  J Cell Physiol       Date:  2003-01       Impact factor: 6.384

9.  Increased expression of interleukin-13 but not interleukin-4 in CD4+ cells from patients with the hyper-IgE syndrome.

Authors:  K O Gudmundsson; O E Sigurjonsson; S Gudmundsson; D Goldblatt; C M R Weemaes; A Haraldsson
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

10.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more
  11 in total

1.  Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.

Authors:  Jia-Ning Wang; Ning Shi; Wei-Bing Xie; Xia Guo; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

2.  DNA Methylation at Birth is Associated with Childhood Serum Immunoglobulin E Levels.

Authors:  Luhang Han; Akhilesh Kaushal; Hongmei Zhang; Latha Kadalayil; Jiasong Duan; John W Holloway; Wilfried Karmaus; Pratik Banerjee; Shih-Fen Tsai; Hui-Ju Wen; Syed Hasan Arshad; Shu-Li Wang
Journal:  Epigenet Insights       Date:  2021-04-05

3.  New insights into the roles of RGC-32.

Authors:  Qingjie Wang; Xun Qu
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

4.  Response gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4.

Authors:  Peng Zhao; Daiqing Gao; Qingjie Wang; Bingfeng Song; Qianqian Shao; Jintang Sun; Chunyan Ji; Xingang Li; Peng Li; Xun Qu
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

5.  RGC-32 is a novel regulator of the T-lymphocyte cell cycle.

Authors:  Cosmin A Tegla; Cornelia D Cudrici; Vinh Nguyen; Jacob Danoff; Adam M Kruszewski; Dallas Boodhoo; Armugam P Mekala; Sonia I Vlaicu; Ching Chen; Violeta Rus; Tudor C Badea; Horea Rus
Journal:  Exp Mol Pathol       Date:  2015-03-11       Impact factor: 3.362

6.  CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions.

Authors:  Toshimichi Matsui; John E Connolly; Mark Michnevitz; Damien Chaussabel; Chun-I Yu; Casey Glaser; Sasha Tindle; Marc Pypaert; Heidi Freitas; Bernard Piqueras; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

7.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

8.  Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor.

Authors:  Xiaojin An; Yi Jin; Hongnian Guo; Shi-Yin Foo; Brittany L Cully; Jiaping Wu; Huiyan Zeng; Anthony Rosenzweig; Jian Li
Journal:  Circulation       Date:  2009-08-03       Impact factor: 29.690

9.  The effect of food intake on gene expression in human peripheral blood.

Authors:  Amy S Leonardson; Jun Zhu; Yanqing Chen; Kai Wang; John R Lamb; Marc Reitman; Valur Emilsson; Eric E Schadt
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

Review 10.  Response Gene to Complement 32 in Vascular Diseases.

Authors:  Xiao-Bing Cui; Shi-You Chen
Journal:  Front Cardiovasc Med       Date:  2018-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.